What Samsung Pharmaceutical does

Samsung Pharmaceutical (삼성제약 주식회사) is a South Korean pharmaceutical manufacturer established in 1929 and headquartered at 10 Jeyakgongdan 4-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do. The company produces five product categories from its single Hwaseong manufacturing site: prescription medicines (53 SKUs spanning NSAIDs, fluoroquinolone antibiotics, SGLT2 inhibitor combinations, corticosteroids, topical anesthetics, BPH and hair-loss therapeutics), general pharmaceuticals (14 SKUs, e.g., cardiovascular Woowhangchongshimwon, liver Sseulgidam, digestive Gasmyungsoo F, ophthalmic Eyetect), quasi-medicines (5 SKUs, e.g., Gasmyungsoo sparkling digestants), OTC drinks (4 SKUs, including YA energy drink and WON SSANGWHA), and 24+ functional foods covering probiotics, melatonin, nattokinase and high-dose vitamin C. Core technology is conventional small-molecule and herbal pharmaceutical formulation and packaging.

The company operates a sales-led, domestically focused go-to-market. Prescription medicines are sold direct to hospitals and clinics; general pharmaceuticals, quasi-medicines and functional foods are distributed through retail pharmacies; and OTC drinks reach consumers via convenience-store chains (Seven-Eleven, Mini-Stop, Family-Mart) and expressway service areas. Marketing relies on long-running television advertising campaigns (active since the 1980s for brands such as Sulgidam and Gasmyungsoo), a corporate website serving as both product catalog and IR portal, and a multi-tier product-authenticity verification labeling system. Pricing is not publicly disclosed and revenue is generated through unit-product sales (one-time license per SKU).

Samsung Pharmaceutical is a privately held Korean corporation (no public ticker identified in source data) with no disclosed parent entity or concentrated controlling shareholder. Governance is exercised through a Representative Director (Jeong Seong-taek), two internal directors, two newly appointed external directors and an auditor following the 72nd shareholders meeting on March 26, 2026. In June 2026 it disclosed a co-development partnership with GemVax & Kael to seek Korean conditional approval of GV1001 for Progressive Supranuclear Palsy, its first disclosed move into a neurology/orphan-disease indication. Operations remain entirely domestic within South Korea and no international footprint or M&A activity is recorded.

Name

Samsung Pharmaceutical

Legal name

삼성제약 주식회사

Website

https://sspharm.co.kr

Company type

Private

Founded year

1929

Operating status

Operating

Short description

Samsung Pharmaceutical is a South Korean pharmaceutical manufacturer founded in 1929 that produces prescription medicines, general pharmaceuticals, quasi-medicines, OTC drinks, and functional foods for Korean hospitals, pharmacies, and convenience-store retail channels.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

akta.pro secondary industries

Oral Solid Dose (OSD) Generics (HLAIABAD), Generic Hospital & Institutional Products (HLAIABAL), OTC Medicines & Consumer Health Products Distribution (CRAOAHAB)

Keywords

• Prescription pharmaceuticals
• OTC medicines
• Health functional foods
• Anti-inflammatory drugs
• Digestive medicines

Headquarters

HQ city

Hwaseodong

HQ country

South Korea

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Sales: Revenue generated from manufacturing and selling prescription medicines, general pharmaceuticals, quasi-medicines, OTC drinks, and functional food products through pharmacies, hospitals, and retail channels in South Korea.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Samsung Pharmaceutical (삼성제약) is a South Korea-based pharmaceutical manufacturer founded in 1929 that researches, develops, and produces prescription medicines, general (OTC) pharmaceuticals, quasi-medicines, OTC drinks, and health functional foods. Its portfolio spans 53 prescription medicines, 14 general pharmaceuticals, 5 quasi-medicines, 4 OTC drinks, and 24+ functional foods covering anti-inflammatory/analgesic, digestive, liver support, antibiotic, and nutritional supplement categories. Manufacturing is carried out at the company's Hwaseong-si, Gyeonggi-do facility and products are distributed domestically through hospitals, clinics, pharmacies, and convenience stores.

Product overview

Samsung Pharmaceutical (삼성제약) is a Korean pharmaceutical company established in 1929 offering a diverse portfolio of prescription medicines, general pharmaceuticals, quasi-medicines, OTC drinks, and functional foods. The company's product range includes anti-inflammatory analgesics (Toranzin, Acecrona, Celecoxib, Loxoprofen), digestive medicines (Gasmyungsoo family products), liver support supplements (Sseulgidam), energy drinks (YA), and various functional foods including probiotics, melatonin supplements, and nattokinase products. The company also manufactures prescription antibiotics, ophthalmic supplements (Eyetect), and traditional herbal beverages.

Differentiator

Problem solved

Functional benefit

Products and services

• Toranzin inj. 50mg/100mg Injectable analgesic prescribed for acute or chronic moderate-to-severe pain, cancer-related pain, and post-operative or post-diagnostic pain; distributed to hospitals and clinics.
• Samsung Talniflumate tab. Prescription tablet indicated for rheumatic arthritis, osteoarthritis, pain and inflammation from external injury or surgery, and ENT inflammation (pharyngitis, tonsillitis, otitis, sinusitis).
• Acecrona tab. (Aceclofenac 100mg) Prescription NSAID tablet for rheumatic arthritis, rheumatoid spondylitis, osteoarthritis, and inflammation caused by various conditions.
• SAMSUNG Loxoprofen Sodium tab. Prescription anti-inflammatory and pain relief tablet for chronic rheumatoid arthritis, osteoarthritis, backache, scapulohumeral periarthritis, and related musculoskeletal conditions.
• SAMSUNG Celecoxib Cap. 200mg Prescription COX-2 inhibitor capsule for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute pain, and primary dysmenorrhea.
• SAMSUNG Moniflumate inj. 350mg Prescription injectable for pain relief and anti-inflammation in respiratory diseases, otolaryngology diseases, and osteoarthritis.
• Samsung Finasteride 1mg tablet Prescription finasteride 1mg tablet for treatment of male pattern hair loss (androgenetic alopecia).
• Samsung Dutasteride 0.5mg capsule Prescription dutasteride 0.5mg capsule for treatment of benign prostatic hyperplasia (BPH).
• Mphametha (Empagliflozin combination) tablet Prescription SGLT2 inhibitor combination medication for type 2 diabetes treatment.
• Samsung Levofloxacin injection and Ciprofloxacin tablet Prescription fluoroquinolone antibiotic injection and tablet for various bacterial infections.
• Leskain Cream (Lidocaine cream) Topical lidocaine anesthetic cream for local anesthesia; lidocaine-class product.
• SAMSUNG Woowhangchongshimwon Suspension OTC circulatory-system medicine containing cow bezoar and musk for urgency relief and health maintenance; sold through pharmacies.
• Sseulgidam 50mg Soft Capsule OTC liver-disorder soft capsule containing UDCA and B-vitamins for liver protection and fatigue recovery.
• Gasmyungsoo F Liquid OTC digestive liquid containing 11 herbal ingredients (including cinnamon, clove, cardamom) for indigestion, bloating, nausea, and loss of appetite.
• Eyetect Soft Capsule OTC nutritional supplement combining snake oil (sa-yu) with Vitamin A/D for dry eyes, night blindness, and vision support.
• Gasmyungsoo Liquid Quasi-medicine sparkling digestant with 4 herbal ingredients for indigestion, excessive drinking, overeating, and dyspepsia; marketed as Korea's first sparkling digestant.
• Gasmyungsoo Gold Liquid Improved quasi-medicine sparkling digestant with added L-menthol for enhanced freshness and comfortable digestion.
• YA Energy Drink Carbonated OTC energy drink with guarana extract, taurine, red ginseng extract, and B-vitamins for energy and fatigue recovery; sold through convenience stores and expressway service areas.
• WON SSANGWHA Traditional herbal OTC beverage containing ssanghwa extract for cold relief and general wellness.
• Samsung Pharm Melarium (plant-based melatonin) Functional food sleep-support supplement with plant-based melatonin for relaxation and improved sleep quality.
• SAMSUNG BOM FAMILY PREMIUM PROBIOTICS Premium probiotic functional food supplement for digestive health and immune support.
• SAMSUNG HK NATTOKINASE GOLD Nattokinase functional food supplement for cardiovascular health support.
• VITAMIN C 3000 High-dose vitamin C functional food supplement for immune support and antioxidant benefits.
• Enzyme Myeongsu (효소명수) Digestive enzyme drink formulated for modern dietary patterns; consumer health product.
• Riabak (리아백스) Pancreatic cancer prescription drug co-developed with GemVax & Kael; re-launched for the Korean market.
• Budy Ranch (버디랑) Golf-themed functional beverage product tied to the Korean golf leisure trend.

Segments1 record

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• GemVax & KaelminorStrategic or Co-development Partner · 17 June 2026Samsung Pharmaceutical and GemVax have jointly applied with regulatory authorities for conditional approval of GV1001 for PSP (Progressive Supranuclear Palsy) in Korea. This represents a collaborative drug development partnership for a novel therapeutic indication.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Chong Kun Dang Pharmaceutical: Long-standing Korean pharma with prescription, OTC, and functional food offerings. Similar heritage positioning and domestic-focused distribution to Samsung Pharm.
• Daewoong Pharmaceutical: Korean pharma manufacturer with diversified portfolio of prescription drugs, OTC, and consumer health products. Directly comparable in business model and channel structure.
• Yuhan Corporation: Major Korean pharmaceutical manufacturer with broad Rx, OTC, and consumer health portfolio across domestic and international markets. Highly comparable domestic Korean pharma with similar product breadth.
• Kwang Dong Pharmaceutical: Korean OTC and consumer health specialist with strong position in quasi-medicines, energy drinks, and digestive products. Direct competitor to Samsung Pharm's OTC/functional food portfolio.
• Bukwang Pharmaceutical: Mid-cap Korean pharma focused on CNS, GI, and specialty drugs with established OTC presence. Closely comparable mid-sized domestic pharma peer.
• Dong-A Pharmaceutical: Established Korean pharma with prescription, OTC, and functional food lines sold through similar pharmacy and hospital channels. Closely comparable mid-cap Korean pharma portfolio.

Emerging players

• Kolmar Korea: Korean health products manufacturer with significant functional food and OTC capabilities. Comparable in consumer health and quasi-medicines segment.
• WhanIn Pharmaceutical: Korean specialty pharma focused on aesthetics and specialty care pharmaceuticals. Overlaps with Samsung Pharm in specialty Rx and consumer health adjacencies.

Broad incumbents

• Hanmi Pharmaceutical: Larger Korean pharma with greater R&D investment and specialty drug pipeline. Comparable business model but significantly bigger scale and innovation footprint.
• GC Biopharma: Major Korean vaccine and plasma products manufacturer. Larger player in Korean pharma, comparable in domestic market presence but broader biologics portfolio.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Samsung Pharmaceutical